Standard BioTools Inc.
LAB | NASDAQ
$0.74
-$0.03 (-3.87%)
At close: Sep 21, 2026, 4:00 PM ET
$0.73
-$0.01 (-1.35%)
Pre-market:
Sep 22, 2026, 4:00 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 118.21M | 166.73M | 51.7M | 81.31M | 28.45M | 68.52M |
Short-Term Investments | 69.36M | 126.15M | 63.19M | 84.48M | n/a | n/a |
Long-Term Investments | 25.7M | n/a | n/a | n/a | 1M | n/a |
Other Long-Term Assets | 3.15M | 24.83M | 2.29M | 3.11M | 3.69M | 2.66M |
Receivables | 13.43M | 33.61M | 19.66M | 17.28M | 18.32M | 25.42M |
Inventory | 19.98M | 40.74M | 20.53M | 21.47M | 20.83M | 19.69M |
Other Current Assets | 233.28M | 8.66M | 3.13M | 4.28M | 16K | n/a |
Total Current Assets | 454.26M | 375.88M | 158.22M | 208.82M | 72.07M | 117.66M |
Property-Plant & Equipment | 46.01M | 71.38M | 54.85M | 59.54M | 65.15M | 55.65M |
Goodwill & Intangibles | n/a | 140.25M | 107.72M | 118.85M | 134.31M | 148.79M |
Total Long-Term Assets | 113.49M | 236.46M | 164.85M | 181.5M | 203.15M | 207.09M |
Total Assets | 567.75M | 612.34M | 323.07M | 390.31M | 275.21M | 324.76M |
Account Payables | 5.41M | 12.28M | 9.24M | 7.91M | 10.6M | 9.22M |
Deferred Revenue | 38.95M | 18.59M | 16.74M | 14.44M | 15.48M | 16.39M |
Short-Term Debt | 5.49M | n/a | 59.53M | 2.08M | 6.84M | n/a |
Other Current Liabilities | 58.46M | 14.71M | 12.05M | 3.97M | 8.67M | 11.21M |
Total Current Liabilities | 108.31M | 65.89M | 109.33M | 43.44M | 49.57M | 54.25M |
Long-Term Debt | 299K | 299K | 3.98M | 62.81M | 64.21M | 54.22M |
Other Long-Term Liabilities | 1.21M | 6.96M | 312.32M | 312.21M | 882K | 1.33M |
Total Long-Term Liabilities | 35.15M | 74.73M | 361.79M | 428.33M | 131.05M | 131.46M |
Total Liabilities | 143.46M | 140.62M | 471.12M | 471.78M | 180.62M | 185.71M |
Total Debt | 30.83M | 33M | 98.21M | 102.66M | 111.65M | 95.38M |
Book Value | 424.29M | 471.72M | -148.05M | -81.47M | 94.6M | 139.05M |
Book Value Per Share | 1.11 | 1.34 | -1.87 | -1.04 | 1.25 | 1.93 |
Common Stock | 404K | 396K | 83K | 80K | 77K | 75K |
Retained Earnings | -1.26B | -1.19B | -1B | -926.1M | -736M | -676.76M |
Comprehensive Income | -1.49M | 1.23M | -2.22M | -1.9M | -907K | 112K |
Shareholders Equity | 424.29M | 471.72M | -148.05M | -81.47M | 94.6M | 139.05M |
Total Investments | 95.06M | 126.15M | 63.19M | 84.48M | 1M | n/a |
Add to Watchlist
Select watchlists to add or remove LAB